APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paclitaxel

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Selected research

Industry Growth & Trends

Global Paclitaxel Industry Growth and Trends Forecast to 2032

26 December 2025108 pages

Choose your research edition.

Industry ResearchPaclitaxel Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Paclitaxel Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Paclitaxel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paclitaxel Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Paclitaxel Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Paclitaxel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paclitaxel market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paclitaxel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paclitaxel.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paclitaxel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paclitaxel Market by Company

Phyton

ScinoPharm

Novasep

Samyang

Polymed

TAPI (Teva)

Fresenius-kabi

Huiang biopharma

Southpharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

Paclitaxel Segment by Type

Natural Paclitaxel API

Semi-synthetic Paclitaxel API

Paclitaxel Segment by Application

Ovarian Cancer

Cervical Cancer

Breast Cancer

Others

Paclitaxel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paclitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natural Paclitaxel API Table 2. Major Company of Semi-synthetic Paclitaxel API Table 3. Global Paclitaxel Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Paclitaxel Sales by Type (2021-2026) & (kg) Table 5. Global Paclitaxel Sales Market Share in Volume by Type (2021-2026) Table 6. Global Paclitaxel Sales by Type (2021-2026) & (US$ Million) Table 7. Global Paclitaxel Sales Market Share in Value by Type (2021-2026) Table 8. Global Paclitaxel Price by Type (2021-2026) & (USD/kg) Table 9. Global Paclitaxel Sales by Type (2027-2032) & (kg) Table 10. Global Paclitaxel Sales Market Share in Volume by Type (2027-2032) Table 11. Global Paclitaxel Sales by Type (2027-2032) & (US$ Million) Table 12. Global Paclitaxel Sales Market Share in Value by Type (2027-2032) Table 13. Global Paclitaxel Price by Type (2027-2032) & (USD/kg) Table 14. North America Paclitaxel Sales by Type (2021-2026) & (kg) Table 15. North America Paclitaxel Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Paclitaxel Sales by Type (2021-2026) & (kg) Table 17. Europe Paclitaxel Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Paclitaxel Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Paclitaxel Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Paclitaxel Sales by Type (2021-2026) & (kg) Table 21. Latin America Paclitaxel Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Paclitaxel Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Paclitaxel Sales by Type (2021-2026) & (US$ Million) Table 24. Paclitaxel Industry Trends Table 25. Paclitaxel Industry Drivers Table 26. Paclitaxel Industry Opportunities and Challenges Table 27. Paclitaxel Industry Restraints Table 28. Global Paclitaxel Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Paclitaxel Revenue Market Share by Company (2021-2026) Table 30. Global Paclitaxel Sales by Company (2021-2026) & (kg) Table 31. Global Paclitaxel Sales Share by Company (2021-2026) Table 32. Global Paclitaxel Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Paclitaxel Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Paclitaxel Major Company Production Sites and Headquarters Table 35. Global Paclitaxel Company, Product Type & Application Table 36. Global Paclitaxel Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Paclitaxel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Paclitaxel Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Paclitaxel Sales by Region (2021-2026) & (kg) Table 41. Global Paclitaxel Sales Market Share in Volume by Region (2021-2026) Table 42. Global Paclitaxel Sales by Region (2021-2026) & (US$ Million) Table 43. Global Paclitaxel Sales Market Share in Value by Region (2021-2026) Table 44. Global Paclitaxel Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Paclitaxel Sales by Region (2027-2032) & (kg) Table 46. Global Paclitaxel Sales Market Share in Volume by Region (2027-2032) Table 47. Global Paclitaxel Sales by Region (2027-2032) & (US$ Million) Table 48. Global Paclitaxel Sales Market Share in Value by Region (2027-2032) Table 49. Global Paclitaxel Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Paclitaxel Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Paclitaxel Sales by Application (2021-2026) & (kg) Table 52. Global Paclitaxel Sales Market Share in Volume by Application (2021-2026) Table 53. Global Paclitaxel Sales by Application (2021-2026) & (US$ Million) Table 54. Global Paclitaxel Sales Market Share in Value by Application (2021-2026) Table 55. Global Paclitaxel Price by Application (2021-2026) & (USD/kg) Table 56. Global Paclitaxel Sales by Application (2027-2032) & (kg) Table 57. Global Paclitaxel Sales Market Share in Volume by Application (2027-2032) Table 58. Global Paclitaxel Sales by Application (2027-2032) & (US$ Million) Table 59. Global Paclitaxel Sales Market Share in Value by Application (2027-2032) Table 60. Global Paclitaxel Price by Application (2027-2032) & (USD/kg) Table 61. North America Paclitaxel Sales by Application (2021-2026) & (kg) Table 62. North America Paclitaxel Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Paclitaxel Sales by Application (2021-2026) & (kg) Table 64. Europe Paclitaxel Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Paclitaxel Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Paclitaxel Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Paclitaxel Sales by Application (2021-2026) & (kg) Table 68. Latin America Paclitaxel Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Paclitaxel Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Paclitaxel Sales by Application (2021-2026) & (US$ Million) Table 71. Phyton Company Information Table 72. Phyton Business Overview Table 73. Phyton Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Phyton Paclitaxel Product Portfolio Table 75. Phyton Recent Development Table 76. ScinoPharm Company Information Table 77. ScinoPharm Business Overview Table 78. ScinoPharm Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. ScinoPharm Paclitaxel Product Portfolio Table 80. ScinoPharm Recent Development Table 81. Novasep Company Information Table 82. Novasep Business Overview Table 83. Novasep Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Novasep Paclitaxel Product Portfolio Table 85. Novasep Recent Development Table 86. Samyang Company Information Table 87. Samyang Business Overview Table 88. Samyang Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Samyang Paclitaxel Product Portfolio Table 90. Samyang Recent Development Table 91. Polymed Company Information Table 92. Polymed Business Overview Table 93. Polymed Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Polymed Paclitaxel Product Portfolio Table 95. Polymed Recent Development Table 96. TAPI (Teva) Company Information Table 97. TAPI (Teva) Business Overview Table 98. TAPI (Teva) Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. TAPI (Teva) Paclitaxel Product Portfolio Table 100. TAPI (Teva) Recent Development Table 101. Fresenius-kabi Company Information Table 102. Fresenius-kabi Business Overview Table 103. Fresenius-kabi Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Fresenius-kabi Paclitaxel Product Portfolio Table 105. Fresenius-kabi Recent Development Table 106. Huiang biopharma Company Information Table 107. Huiang biopharma Business Overview Table 108. Huiang biopharma Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Huiang biopharma Paclitaxel Product Portfolio Table 110. Huiang biopharma Recent Development Table 111. Southpharma Company Information Table 112. Southpharma Business Overview Table 113. Southpharma Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Southpharma Paclitaxel Product Portfolio Table 115. Southpharma Recent Development Table 116. Yunnan Hande Company Information Table 117. Yunnan Hande Business Overview Table 118. Yunnan Hande Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. Yunnan Hande Paclitaxel Product Portfolio Table 120. Yunnan Hande Recent Development Table 121. Hainan Yew Pharm Company Information Table 122. Hainan Yew Pharm Business Overview Table 123. Hainan Yew Pharm Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. Hainan Yew Pharm Paclitaxel Product Portfolio Table 125. Hainan Yew Pharm Recent Development Table 126. Jiangsu Yew Biotechnology Company Information Table 127. Jiangsu Yew Biotechnology Business Overview Table 128. Jiangsu Yew Biotechnology Paclitaxel Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. Jiangsu Yew Biotechnology Paclitaxel Product Portfolio Table 130. Jiangsu Yew Biotechnology Recent Development Table 131. North America Paclitaxel Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 132. North America Paclitaxel Sales by Country (2021-2026) & (kg) Table 133. North America Paclitaxel Sales Market Share by Country (2021-2026) Table 134. North America Paclitaxel Sales Forecast by Country (2027-2032) & (kg) Table 135. North America Paclitaxel Sales Market Share Forecast by Country (2027-2032) Table 136. North America Paclitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Paclitaxel Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Paclitaxel Market Share by Country (2021-2026) Table 139. North America Paclitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Paclitaxel Market Share Forecast by Country (2027-2032) Table 141. Europe Paclitaxel Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 142. Europe Paclitaxel Sales by Country (2021-2026) & (kg) Table 143. Europe Paclitaxel Sales Market Share by Country (2021-2026) Table 144. Europe Paclitaxel Sales Forecast by Country (2027-2032) & (kg) Table 145. Europe Paclitaxel Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Paclitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Paclitaxel Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Paclitaxel Market Share by Country (2021-2026) Table 149. Europe Paclitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Paclitaxel Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Paclitaxel Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Paclitaxel Sales by Country (2021-2026) & (kg) Table 153. Asia-Pacific Paclitaxel Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Paclitaxel Sales Forecast by Country (2027-2032) & (kg) Table 155. Asia-Pacific Paclitaxel Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Paclitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Paclitaxel Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Paclitaxel Market Share by Country (2021-2026) Table 159. Asia-Pacific Paclitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Paclitaxel Market Share Forecast by Country (2027-2032) Table 161. Latin America Paclitaxel Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 162. Latin America Paclitaxel Sales by Country (2021-2026) & (kg) Table 163. Latin America Paclitaxel Sales Market Share by Country (2021-2026) Table 164. Latin America Paclitaxel Sales Forecast by Country (2027-2032) & (kg) Table 165. Latin America Paclitaxel Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Paclitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Paclitaxel Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Paclitaxel Market Share by Country (2021-2026) Table 169. Latin America Paclitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Paclitaxel Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Paclitaxel Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Paclitaxel Sales by Country (2021-2026) & (kg) Table 173. Middle East and Africa Paclitaxel Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Paclitaxel Sales Forecast by Country (2027-2032) & (kg) Table 175. Middle East and Africa Paclitaxel Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Paclitaxel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Paclitaxel Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Paclitaxel Market Share by Country (2021-2026) Table 179. Middle East and Africa Paclitaxel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Paclitaxel Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Paclitaxel Distributors List Table 184. Paclitaxel Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Paclitaxel Image Figure 2. Global Paclitaxel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paclitaxel Market Size (2021-2032) & (US$ Million) Figure 4. Global Paclitaxel Sales (2021-2032) & (kg) Figure 5. Natural Paclitaxel API Image Figure 6. Global Natural Paclitaxel API Sales YoY Growth (2021-2032) & (kg) Figure 7. Semi-synthetic Paclitaxel API Image Figure 8. Global Semi-synthetic Paclitaxel API Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Paclitaxel Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Paclitaxel Market Share by Type 2025 VS 2032 Figure 11. North America Paclitaxel Sales Market Share in Volume by Type in 2025 Figure 12. North America Paclitaxel Sales Market Share in Value by Type in 2025 Figure 13. Europe Paclitaxel Sales Market Share in Volume by Type in 2025 Figure 14. Europe Paclitaxel Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Paclitaxel Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Paclitaxel Sales Market Share in Value by Type in 2025 Figure 17. Latin America Paclitaxel Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Paclitaxel Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Paclitaxel Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Paclitaxel Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Paclitaxel Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Ovarian Cancer Image Figure 24. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (kg) Figure 25. Cervical Cancer Image Figure 26. Global Cervical Cancer Sales YoY Growth (2021-2032) & (kg) Figure 27. Breast Cancer Image Figure 28. Global Breast Cancer Sales YoY Growth (2021-2032) & (kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (kg) Figure 31. Global Paclitaxel Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Paclitaxel Market Share by Application 2025 VS 2032 Figure 33. North America Paclitaxel Sales Market Share in Volume by Application in 2025 Figure 34. North America Paclitaxel Sales Market Share in Value by Application in 2025 Figure 35. Europe Paclitaxel Sales Market Share in Volume by Application in 2025 Figure 36. Europe Paclitaxel Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Paclitaxel Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Paclitaxel Sales Market Share in Value by Application in 2025 Figure 39. Latin America Paclitaxel Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Paclitaxel Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Paclitaxel Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Paclitaxel Sales Market Share in Value by Application in 2025 Figure 43. North America Paclitaxel Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. North America Paclitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Paclitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Paclitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Paclitaxel Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Europe Paclitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Paclitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Paclitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Paclitaxel Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Asia-Pacific Paclitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Paclitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Paclitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Paclitaxel Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Latin America Paclitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Paclitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Paclitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Paclitaxel Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 60. Middle East and Africa Paclitaxel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Paclitaxel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Paclitaxel Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Paclitaxel Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Paclitaxel Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API
Applications
  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Others
Companies covered
  • Phyton
  • ScinoPharm
  • Novasep
  • Samyang
  • Polymed
  • TAPI (Teva)
  • Fresenius-kabi
  • Huiang biopharma
  • Southpharma
  • Yunnan Hande
  • Hainan Yew Pharm
  • Jiangsu Yew Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paclitaxel Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paclitaxel Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paclitaxel Market by Type
  6. 1.3.1 Natural Paclitaxel API
  7. 1.3.2 Semi-synthetic Paclitaxel API
  8. 1.4 Global Paclitaxel Market Size by Type
  9. 1.4.1 Global Paclitaxel Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Paclitaxel Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Paclitaxel Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Paclitaxel Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Paclitaxel Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Paclitaxel Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Paclitaxel Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Paclitaxel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paclitaxel Industry Trends
  2. 2.2 Paclitaxel Industry Drivers
  3. 2.3 Paclitaxel Industry Opportunities and Challenges
  4. 2.4 Paclitaxel Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paclitaxel Revenue (2021-2026)
  2. 3.2 Global Top Players by Paclitaxel Sales (2021-2026)
  3. 3.3 Global Top Players by Paclitaxel Price (2021-2026)
  4. 3.4 Global Paclitaxel Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paclitaxel Major Company Production Sites & Headquarters
  6. 3.6 Global Paclitaxel Company, Product Type & Application
  7. 3.7 Global Paclitaxel Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paclitaxel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paclitaxel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paclitaxel Tier 1, Tier 2, and Tier 3
4 Paclitaxel Regional Status and Outlook
  1. 4.1 Global Paclitaxel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paclitaxel Historic Market Size by Region
  3. 4.2.1 Global Paclitaxel Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paclitaxel Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paclitaxel Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paclitaxel Forecasted Market Size by Region
  7. 4.3.1 Global Paclitaxel Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paclitaxel Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paclitaxel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paclitaxel by Application
  1. 5.1 Paclitaxel Market by Application
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Cervical Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Others
  6. 5.2 Global Paclitaxel Market Size by Application
  7. 5.2.1 Global Paclitaxel Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Paclitaxel Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Paclitaxel Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Paclitaxel Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Paclitaxel Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Paclitaxel Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Paclitaxel Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Paclitaxel Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Phyton
  2. 6.1.1 Phyton Company Information
  3. 6.1.2 Phyton Business Overview
  4. 6.1.3 Phyton Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Phyton Paclitaxel Product Portfolio
  6. 6.1.5 Phyton Recent Developments
  7. 6.2 ScinoPharm
  8. 6.2.1 ScinoPharm Company Information
  9. 6.2.2 ScinoPharm Business Overview
  10. 6.2.3 ScinoPharm Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ScinoPharm Paclitaxel Product Portfolio
  12. 6.2.5 ScinoPharm Recent Developments
  13. 6.3 Novasep
  14. 6.3.1 Novasep Company Information
  15. 6.3.2 Novasep Business Overview
  16. 6.3.3 Novasep Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novasep Paclitaxel Product Portfolio
  18. 6.3.5 Novasep Recent Developments
  19. 6.4 Samyang
  20. 6.4.1 Samyang Company Information
  21. 6.4.2 Samyang Business Overview
  22. 6.4.3 Samyang Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Samyang Paclitaxel Product Portfolio
  24. 6.4.5 Samyang Recent Developments
  25. 6.5 Polymed
  26. 6.5.1 Polymed Company Information
  27. 6.5.2 Polymed Business Overview
  28. 6.5.3 Polymed Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Polymed Paclitaxel Product Portfolio
  30. 6.5.5 Polymed Recent Developments
  31. 6.6 TAPI (Teva)
  32. 6.6.1 TAPI (Teva) Company Information
  33. 6.6.2 TAPI (Teva) Business Overview
  34. 6.6.3 TAPI (Teva) Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 TAPI (Teva) Paclitaxel Product Portfolio
  36. 6.6.5 TAPI (Teva) Recent Developments
  37. 6.7 Fresenius-kabi
  38. 6.7.1 Fresenius-kabi Company Information
  39. 6.7.2 Fresenius-kabi Business Overview
  40. 6.7.3 Fresenius-kabi Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Fresenius-kabi Paclitaxel Product Portfolio
  42. 6.7.5 Fresenius-kabi Recent Developments
  43. 6.8 Huiang biopharma
  44. 6.8.1 Huiang biopharma Company Information
  45. 6.8.2 Huiang biopharma Business Overview
  46. 6.8.3 Huiang biopharma Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Huiang biopharma Paclitaxel Product Portfolio
  48. 6.8.5 Huiang biopharma Recent Developments
  49. 6.9 Southpharma
  50. 6.9.1 Southpharma Company Information
  51. 6.9.2 Southpharma Business Overview
  52. 6.9.3 Southpharma Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Southpharma Paclitaxel Product Portfolio
  54. 6.9.5 Southpharma Recent Developments
  55. 6.10 Yunnan Hande
  56. 6.10.1 Yunnan Hande Company Information
  57. 6.10.2 Yunnan Hande Business Overview
  58. 6.10.3 Yunnan Hande Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yunnan Hande Paclitaxel Product Portfolio
  60. 6.10.5 Yunnan Hande Recent Developments
  61. 6.11 Hainan Yew Pharm
  62. 6.11.1 Hainan Yew Pharm Company Information
  63. 6.11.2 Hainan Yew Pharm Business Overview
  64. 6.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hainan Yew Pharm Paclitaxel Product Portfolio
  66. 6.11.5 Hainan Yew Pharm Recent Developments
  67. 6.12 Jiangsu Yew Biotechnology
  68. 6.12.1 Jiangsu Yew Biotechnology Company Information
  69. 6.12.2 Jiangsu Yew Biotechnology Business Overview
  70. 6.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Portfolio
  72. 6.12.5 Jiangsu Yew Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America Paclitaxel Sales by Country
  2. 7.1.1 North America Paclitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paclitaxel Sales by Country (2021-2026)
  4. 7.1.3 North America Paclitaxel Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paclitaxel Market Size by Country
  6. 7.2.1 North America Paclitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paclitaxel Market Size by Country (2021-2026)
  8. 7.2.3 North America Paclitaxel Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paclitaxel Sales by Country
  2. 8.1.1 Europe Paclitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paclitaxel Sales by Country (2021-2026)
  4. 8.1.3 Europe Paclitaxel Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paclitaxel Market Size by Country
  6. 8.2.1 Europe Paclitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paclitaxel Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paclitaxel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paclitaxel Sales by Country
  2. 9.1.1 Asia-Pacific Paclitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paclitaxel Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paclitaxel Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paclitaxel Market Size by Country
  6. 9.2.1 Asia-Pacific Paclitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paclitaxel Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paclitaxel Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paclitaxel Sales by Country
  2. 10.1.1 South America Paclitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paclitaxel Sales by Country (2021-2026)
  4. 10.1.3 South America Paclitaxel Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paclitaxel Market Size by Country
  6. 10.2.1 South America Paclitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paclitaxel Market Size by Country (2021-2026)
  8. 10.2.3 South America Paclitaxel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paclitaxel Sales by Country
  2. 11.1.1 Middle East and Africa Paclitaxel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paclitaxel Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paclitaxel Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paclitaxel Market Size by Country
  6. 11.2.1 Middle East and Africa Paclitaxel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paclitaxel Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paclitaxel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paclitaxel Value Chain Analysis
  2. 12.1.1 Paclitaxel Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paclitaxel Production Mode & Process
  7. 12.2 Paclitaxel Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paclitaxel Distributors
  10. 12.2.3 Paclitaxel Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst